EML4 and cancer: To date, in studies from a variety of human cancer types, the reported fusion partners of ALK have included NPM [1], EML4 [8], MSN [9], TPM3 [10,11], ATIC [12-14], TFG [15], CARS [16], CLTC [17], and KIF5B [18].